ماذا تفعل عندما لا يحقق علاج الخط الأول نمو الشعر في الثعلبة البقعية المتوسطة إلى الشديدة

References

• The AA severity definitions used in this living guideline are based primarily on the extent of scalp hair loss, with limited (mild) hair loss representing 1–20% scalp involvement, moderate hair loss representing 21–49% scalp involvement and severe hair loss representing 50–100% scalp involvement.
• Consider a course of oral corticosteroids (e.g. prednisolone 0.5 mg kg−1 per day tapering over 6–12 weeks) in people with moderate-to-severe AA.
• Consider ciclosporin, azathioprine or methotrexate as monotherapy or in combination with oral corticosteroids as treatment options in people with moderate-to-severe AA, balancing benefits, risks of adverse effects, and patient risk factors.
• Ultimately, the aim of treatment is complete terminal hair regrowth on the scalp and any other body site affected.